SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001674796-24-000015
Filing Date
2024-06-05
Accepted
2024-06-04 17:47:52
Documents
37
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 HST GLOBAL, INC. - FORM 10-Q SEC FILING hstc-20240331.htm   iXBRL 10-Q 191106
2 exhibit31-1.htm EX-31 8078
3 exhibit31-2.htm EX-31 8050
4 exhibit32-1.htm EX-32 3781
5 exhibit32-2.htm EX-32 3739
  Complete submission text file 0001674796-24-000015.txt   1211272

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hstc-20240331_cal.xml EX-101.CAL 16095
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hstc-20240331_def.xml EX-101.DEF 22166
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT hstc-20240331_lab.xml EX-101.LAB 82134
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hstc-20240331_pre.xml EX-101.PRE 65773
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hstc-20240331.xsd EX-101.SCH 13195
41 EXTRACTED XBRL INSTANCE DOCUMENT hstc-20240331_htm.xml XML 73859
Mailing Address 150 RESEARCH DR. HAMPTON VA 23666
Business Address 150 RESEARCH DR. HAMPTON VA 23666 757-766-6100
HST Global, Inc. (Filer) CIK: 0000797564 (see all company filings)

IRS No.: 731215433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15303 | Film No.: 241019758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)